Comparison Chart Arrowhead Pharmaceuticals, Inc.

Equities

ARWR

US04280A1007

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 12/05/2026 BST			5-day change	1st Jan Change
79.04 ^USD	+1.67%		+5.49%	+19.05%

05-08	RBC Capital Adjusts Arrowhead Pharmaceuticals Price Target to $87 From $80, Maintains Outperform Speculative Risk Rating	MT
05-08	Arrowhead Pharmaceuticals, Inc., Q2 2026 Earnings Call, May 07, 2026

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5d. change	Varia. Jan 1.	1-year change	5-years change	Capi.	ST	MT	LT
	ARROWHEAD PHARMACEUTICALS, INC.	Bio Therapeutic Drugs	+1.67%	+5.49%	+19.05%	+465.78%	+15.05%	11.13B